Jinthe Van Loenhout
7PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 29, 2023
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser
|Dec 23, 2022
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans
|Dec 23, 2022
Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?Hannah Zaryouh, Jinthe Van Loenhout, Marc Peeters
|Nov 27, 2021
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.Jinthe Van Loenhout, Laurie Freire Boullosa, Delphine Quatannens
|Dec 02, 2020
Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.Jinthe Van Loenhout, Marc Peeters, Annemie Bogaerts
|Jun 21, 2020
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.Tal Flieswasser, Jinthe Van Loenhout, Laurie Freire Boullosa
Pageof 2
Frequent Collaborators
6 joint publications
Evelien Smits
5 joint publications
Filip Lardon
5 joint publications
Christophe Deben
3 joint publications
Jorrit De Waele
3 joint publications
Elly Marcq
3 joint publications
Annemie Bogaerts
2 joint publications
Jonas Van Audenaerde
2 joint publications
Julie Jacobs
2 joint publications
Abraham Lin
2 joint publications
Laurie Freire Boullosa
